Skip to main content
. Author manuscript; available in PMC: 2018 Nov 10.
Published in final edited form as: J Mol Biol. 2017 Oct 13;429(22):3471–3485. doi: 10.1016/j.jmb.2017.10.001

Table 1. Ubiquitin modifying enzymes with allelic variants that have been associated with immunologic monogenic human syndromes.

Online Mendelian Inheritance in Man (OMIM) was queried for human E2s, E3s, and DUBs. Genes were included in the table above if the associated human monogenic syndrome resulted in autoinflammation, immunodeficiency, or lymphoproliferative defects. RING, Really Interesting New Gene. BTB, Broad-Complex, Tramtrack and Bric a brac. POZ, POxvirus and Zinc finger. SUMO, small ubiquitin-like (Ubl) modifier. HECT, Homologous to the E6-AP Carboxyl Terminus. OTU, ovarian tumor.

Gene Alias Class/Domain Location Human Phenotype Molecular Phenotype
E2s
UBE2T FANCT, HSPC150 E2 1q32.1 Fanconi anemia, complementation group T; pancytopenia [3] UBE2T is an E2 that ubiquitinates FANCL and FANCD2; mutation leads to genome instability and bone marrow failure [3]
E3s
BIRC4 XIAP RING E3 Ub ligase Xq25 Lymphoproliferative syndrome, X-linked [4] Restricts apoptosis through interactions with various caspases; mutation leads to increased susceptibility to apoptotic stimuli [4]
CBL C-CBL, RNF55 RING E3 Ub ligase 11q23.3 Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia [5] Ubiquitinates multiple receptor protein-tyrosine kinases; mutations lead to hyper-responsiveness to multiple cytokines and increased proliferation [5]
FANCL POG RING E3 Ub ligase 2p16.1 Fanconi anemia, complementation group L; pancytopenia [6] FANCL monoubiquitinates FANCD2 in response to DNA damage; mutation leads to genome instability and bone marrow failure [6]
MIB1 DIP-1 RING E3 Ub ligase 18q11.2 Left-ventricular noncompaction 7 [7] Reduced NOTCH 1 activity in peripheral blood leading to potential B and T cell defects [7,8]
RBCK1 HOIL-1, HOIL-1L RBR E3 Ub ligase 20p13 Polyglucosan body myopathy 1 with or without immunodeficiency [9] Defects in LUBAC lead to NFKB dysregulation, leading to both immunodeficiency and autoinflammation [9]
RNF31 HOIP RBR E3 Ub ligase 14q12 Multiorgan autoinflammation, combined immunodeficiency, subclinical amylopectinosis, and systemic lymphanqiectasia [10] Phenolype overlaps with HOIL1/RBCK1 mutated patients [10]
RAG1 RNF74 RING E3 Ub ligase 11 p12 Severe combined immunodeficiency, Omenn syndrome [11,12] RAG1 is required for assembling mature antigen receptors on B & T lymphocytes; mutations in the RING domain impairs ubiquitin ligase activity and recombination [11,12]
RNF125 TRAC1 RING E3 Ub ligase 18q12.1 Tenorio syndrome [13] Defects in RIG-I-IPS1-MDA5, interferon, PI3K-Akt signaling leading to a Sjögren-like syndrome [13]
RNF168 RING E3 Ub ligase 3q29 RIDDLE syndrome; immunodeficiency [14] RNF168 is an E3 ubiquitin ligase critical for DNA double-strand break repair; mutations lead to defective DNA repair and immunodeficiency [14]
SLX4 BTB12 BTB/POZ domain; SUMO E3 ligase 16p13.3 Fanconi anemia, complementation group P; pancytopenia [15,16] SLX4 interacts with SUMO-charged E2 UBC9 and functions as a SUMO E3 ligase; important for the local replicative DNA repair response [15,16]
TRAF3 LAP1, CAP1 RING E3 Ub ligase 14q32.32 Possible association with susceptibility to Herpes simplex vims (HSV) encephalitis [17] Dominant-negative mutant TRAF3 impairs responsiveness to TLR3 agonists such as HSV [17]
ITCH AIF4, AIP4, NAPP1 HECT E3 Ub ligase 20q 11.22 Autoimmune disease, multisystem, with facial dysmorphism [18] Cooperates with A20 and CYLD to terminate NFKB signaling; implicated in multiple signaling pathways, mutations lead to immune dysrequlation [18, 19]
DUBS
TNFAIP3 A20 ZnF E3 Ub ligase; OTU domain, DUB 6q23_3 Autoinflammatory syndrome, familial, Behcet-like [20] Mutations leading to truncated A20 increased NFKB activity due to defective removal of K634inked ubiquitin from RIPK1, NEMO, and TRAF6 [20]
OTULIN AIPDS, FAM105B OTU domain, DUB 5p15.2 Autoinflammation, panniculitis, and dermatosis syndrome [21] OTULIN-deflcient patients have increased linear ubiquitination of ASC, NEMO, RIPK1. TNFR1, leading to severe inflammation [21]